Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 May;25(3-4):410-412.
doi: 10.1080/21678421.2023.2299204. Epub 2024 Jan 2.

A report of resources used by clinicians in the UK to support motor neuron disease genomic testing

Affiliations

A report of resources used by clinicians in the UK to support motor neuron disease genomic testing

Jade Howard et al. Amyotroph Lateral Scler Frontotemporal Degener. 2024 May.

Abstract

Genetic testing is a key decision-making point for people with motor neuron disease (MND); to establish eligibility for clinical trials, better understand the cause of their condition, and confirm the potential risk to relatives, who may be able to access predictive testing. Given the wide-reaching implications of MND genetic and predictive testing, it is essential that families are given adequate information, and that staff are provided with appropriate training. In this report we overview the information resources available to people with MND and family members around genetic testing, and the educational and training resources available to staff, based on information obtained through a freedom of information request to UK-based NHS Trusts. MND Association resources were most commonly used in information sharing, though we highlight distinctions between neurology and genetics centers. No respondents identified comprehensive training around MND genetic testing. We conclude with practice implications and priorities for the development of resources and training.

Keywords: Genetics; patient information; training.

PubMed Disclaimer

Conflict of interest statement

The authors report no conflicts of interest. The authors alone are responsible for the content and writing of this article.

Similar articles

Cited by

References

    1. Crook A, McEwen A.. Genetic counselling and testing for neurodegenerative disorders using a proposed standard of practice for ALS/MND: diagnostic testing comes first. Eur J Hum Genet. 2022;30:394–5. - PMC - PubMed
    1. NICE . Shared decision making, NICE guideline. June 17, 2021. Available at: https://www.nice.org.uk/guidance/ng197. Accessed November 27, 2023.
    1. Salmon K, Ross JP, Bertone V, Gobbo M, Anoja N, Karamchandani J, et al. . The value of testing for ATXN2 intermediate repeat expansions in routine clinical practice for amyotrophic lateral sclerosis. Eur J Hum Genet. 2022;30:1205–7. - PMC - PubMed
    1. Crook A, Jacobs C, Newton‐John T, McEwen A.. Genetic counseling and diagnostic genetic testing for familial amyotrophic lateral sclerosis and/or frontotemporal dementia: a qualitative study of client experiences. J Genet Couns. 2022;31:1206–18. - PMC - PubMed
    1. Bekker HL, Winterbottom AE, Gavaruzzi T, Finderup J, Mooney A.. Decision aids to assist patients and professionals in choosing the right treatment for kidney failure. Clin Kidney J. 2023;16:i20–i38. - PMC - PubMed